Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-04-17 to 2025-04-18
Current total value of award: $79.06
Description: 4568054972!LORAZEPAM 2 MG/ML VIALML